CG
TEVA icon

Caprock Group’s Teva Pharmaceuticals TEVA Stock Holding History

Caprock Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.64M Sell
77,986
-73,901
-49% -$2.46M 0.05% 311
2026
Q1 		$4.57M Buy
151,887
+5,471
+4% +$176K 0.11% 157
2025
Q4 		$4.57M Buy
146,416
+5,320
+4% +$131K 0.1% 177
2025
Q3 		$2.59M Buy
+141,096
New +$2.48M 0.06% 280
2025
Q1 		$2.23M Buy
145,411
+1,584
+1% +$28.3K 0.07% 265
2024
Q4 		$3.17M Sell
143,827
-1,543
-1% -$28.1K 0.1% 171
2024
Q3 		$2.62M Buy
145,370
+13,068
+10% +$229K 0.1% 183
2024
Q2 		$2.15M Buy
+132,302
New +$2.04M 0.09% 191
2020
Q1 		– Sell
-23,494
Closed -$230K – 416
2019
Q4 		$230K Sell
23,494
-236
-1% -$2.11K 0.04% 299
2019
Q3 		$163K Buy
23,730
+1,378
+6% +$10.6K 0.03% 328
2019
Q2 		$206K Buy
+22,352
New +$270K 0.04% 308
2017
Q4 		– Sell
-11,117
Closed -$196K – 496
2017
Q3 		$196K Buy
11,117
+997
+10% +$22.4K 0.04% 411
2017
Q2 		$336K Buy
10,120
+2,350
+30% +$72.7K 0.07% 253
2017
Q1 		$249K Buy
+7,770
New +$265K 0.06% 283
2016
Q4 		– Sell
-6,227
Closed -$287K – 394
2016
Q3 		$287K Buy
+6,227
New +$325K 0.07% 266
2016
Q2 		– Sell
-4,642
Closed -$248K – 348
2016
Q1 		$248K Buy
+4,642
New +$272K 0.06% 260

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Caprock Group's TEVA Position: Q2 2026 in Review

Caprock Group reduced its Teva Pharmaceuticals (TEVA) stake by 49% in Q2 2026, selling an estimated $2.46M and leaving 77,986 shares worth $2.64M. The position accounts for 0.05% of the portfolio, ranked #311.

Caprock Group first reported a position in TEVA in Q1 2016 and has held it in 16 quarters since. The position peaked at $4.57M in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Caprock Group held 77,986 shares of Teva Pharmaceuticals worth $2.64M as of Q2 2026.
  • Caprock Group sold 73,901 Teva Pharmaceuticals shares in Q2 2026, an estimated $2.46M.
  • Teva Pharmaceuticals made up 0.05% of Caprock Group's portfolio in Q2 2026, its #311 holding.
  • Caprock Group first reported a position in Teva Pharmaceuticals in Q1 2016 and has held it in 16 quarters since.
  • Caprock Group's Teva Pharmaceuticals position peaked at $4.57M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.